New sedative dose study aims for safer surgery in seniors
NCT ID NCT07333508
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at fospropofol disodium, a sedative, to find the best dose for elderly patients (65 and older) having leg surgery with spinal anesthesia. The goal is to keep patients comfortably asleep without over-sedating them. Sixty participants will receive different doses to determine the amount that works for 95% of people.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- fospropofol disodium
- What this could lead to
- If successful, this could help doctors use a safer, more precise dose of fospropofol for sedation in elderly patients during surgery.
- What could go wrong
- This is a small, early-phase trial with only 60 patients, so results may not apply to everyone. The drug may cause side effects like low blood pressure or breathing problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOWER EXTREMITY SURGERY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430030, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.